Slingshot members are tracking this event:
Sangamo BioSciences Announces New Gene Therapy Clinical Development Program for Treatment Of Hemophilia A
Do you think this event is important to the companies below? How will it affect their stock price?
|Impact on Stocks
Slingshot Insights Explained
Jul 26, 2016
Don’t see a project related to the catalyst you care about?
Related Keywords New Gene Therapy, Hemophilia A, Cdna, Zinc Finger Nuclease Genome